Key Financial Data Of Reporting Company

Immuno-Biological Laboratories Co., Ltd. - Filing #7370747

Concept As at
2023-09-30
2023-07-01 to
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-09-30
2022-07-01 to
2022-09-30
2022-04-01 to
2022-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
365,516,000 JPY
794,621,000 JPY
293,166,000 JPY
Ordinary profit (loss)
30,639,000 JPY
-149,503,000 JPY
-129,668,000 JPY
Net assets
1,105,478,000 JPY
1,078,616,000 JPY
1,232,179,000 JPY
Total assets
1,434,394,000 JPY
1,434,337,000 JPY
1,561,617,000 JPY
Basic earnings (loss) per share
1.68
2.88
-31.10
-8.29
-14.62
Diluted earnings per share
Equity-to-asset ratio
0.771 xbrli:pure
0.752 xbrli:pure
0.789 xbrli:pure
Net cash provided by (used in) operating activities
7,081,000 JPY
26,458,000 JPY
-50,626,000 JPY
Net cash provided by (used in) investing activities
-8,821,000 JPY
30,036,000 JPY
-63,950,000 JPY
Net cash provided by (used in) financing activities
2,996,000 JPY
991,000 JPY
2,995,000 JPY
Cash and cash equivalents
566,074,000 JPY
561,997,000 JPY
340,795,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.